Centerview Partners, the US investment bank boutique, has won a role on two multibillion-dollar cancer-drug deals announced on December 9, advising the target company on both.

Sanofi, the French pharmaceutical company, announced it had agreed to acquire Synthorx, a biotech that specialises in cancer treatments, for $2.5bn in cash. Morgan Stanley, the US bank, is acting as financial adviser to Sanofi, while Centerview is exclusive adviser to Synthorx.